Stomach Neoplasms: all 2,914 studies
Page 7 of 30. Open to participants first (880), then studies with results posted, then the rest; newest registration first within each.
- Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction CancerRecruitingNCT06028737Phase 2/3
- Oral Supplementation of Glutamine on Gastric Cancer Patients After GastrectomyRecruitingNCT06027242Not applicable
- Phase 2 Trial of KN026+KN046±XELOX in HER2-positive Locally Advanced GCRecruitingNCT06023758Phase 2
- Clinical Study on Nutrition Intervention in Patients With Esophageal and Gastric Cancer Treated With ChemotherapyNot yet recruitingNCT06022770Not applicable
- Clinical Study of VG161 Combined With Nivolumab Injection in Patients With Advanced Metastatic Gastric CancerRecruitingNCT06008925Phase 1/2
- A Study of SI-B003, BL-B01D1+SI-B003 and BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Esophageal Cancer, Gastric Cancer, Colorectal Cancer and Other Gastrointestinal TumorsRecruitingNCT06008054Phase 2
- Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid TumorsRecruitingNCT06005493Phase 1/2
- A Single Arm, Phase II Exploratory Clinical Study of Pemitinib in Advanced Gastric Cancer With Previous Standard Therapy Failure the FGFR VariantNot yet recruitingNCT05997459Phase 2
- Disitamab Vedotin, Fruquintinib and Tislelizumab in Second-line Treatment for HER2-positive MGCRecruitingNCT05982834Phase 1/2
- Sintilimab Combined With Modified FLOT Regimen in the Treatment of Metastatic Gastric CancerRecruitingNCT05982301Phase 2
- Feasibility Study of Sentinel Navigation Surgery in Early Gastric Cancer Using Fluorescence (SENORITA4)Not yet recruitingNCT05978882Not applicable
- Characterization of Tissue Biochemical Composition in Gastric Precancerous/Cancerous LesionsRecruitingNCT05977478Not applicable
- Adjuvant Serplulimab and Trastuzuma and Chemotherapy in Her-2+ Gastric CancerRecruitingNCT05975749Phase 2
- Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer PatientsAvailableNCT05974410
- Perioperative Chemotherapy Plus Toripalimab for Epstein-Barr Virus-associated Locally Advanced Gastric or Esophagogastric Junction AdenocarcinomaNot yet recruitingNCT05970627Phase 2
- Effect of Exercise and Enteral Nutrition on SurvivalNot yet recruitingNCT05959226Not applicable
- The Role of Extracellular DNA (ecDNA) in the Occurrence and Development of GastricRecruitingNCT05956847
- To Evaluate the Efficacy and Safety of Cadonilimab With SOX as Neoadjuvant Therapy for Resectable Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.Not yet recruitingNCT05948449Phase 2
- HTL0039732 in Participants With Advanced Solid TumoursRecruitingNCT05944237Phase 1/2
- A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid TumorsRecruitingNCT05941507Phase 1/2
- Genomic and Dietary Aspects in Gastric Cancer RiskNot yet recruitingNCT05934058
- Efficacy and Safety of ESD for the Treatment of Superficial Gastric NeoplasmsRecruitingNCT05930860
- Efficacy and Safety of Disitamab Vedotin Combined With SintilimabNot yet recruitingNCT05928897Phase 2
- Evaluation of a Computer-aided Diagnosis System (CADx) in the Early Detection of Gastric Cancer in France. Cancer in France.RecruitingNCT05928819
- Comparing Modified XELOX Plus Sintilimab With Standard XELOX Plus Sintilimab in First-line Treatment for HER2-negative Gastric/Gastroesophageal Junction AdenocarcinomaRecruitingNCT05918094Phase 3
- Envollizumab Combined With Fruquintinib and SOX Versus SOX for Conversion Therapy in Advanced Gastric CancerNot yet recruitingNCT05914610Phase 3
- Effect of Probiotic Supplements on Gastric Cancer Patients Receiving Neoadjuvant ChemotherapyRecruitingNCT05901779Not applicable
- MicroRNAs From Blood Samples as Biomarkers for Gastric Cancer DetectionRecruitingNCT05901376
- T-Dxd in Combination With Ramucirumab as HER2 Low Gastric or Gastroesophageal Junction (GEJ) AdenocarcinomaRecruitingNCT05894824Phase 1/2
- Cryoablation Combined With Tislelizumab Plus Lenvatinib In Previously Treated Gastric Cancer Liver Metastasis (CASTLE-09)RecruitingNCT05893056Phase 2
- Feasibility and Safety of Robotic Assisted Proximal Gastrectomy With Double-flap Technique for Proximal Early Gastric CancerRecruitingNCT05892289Not applicable
- Laparoscopic Proximal Gastrectomy With Double-flap Technique Versus Laparoscopic Total Gastrectomy With Roux-en-Y Reconstruction for Proximal Early Gastric CancerNot yet recruitingNCT05890339Not applicable
- Adaptive Radiation for Abdominopelvic MetastasesRecruitingNCT05880667Phase 1
- IKS014 in Advanced Solid Tumors That Express HER2RecruitingNCT05872295Phase 1
- Laparoscopic Gastrectomy With D2 Lymphadenectomy Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or NotRecruitingNCT05871099Phase 3
- A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1)RecruitingNCT05865002Phase 1
- Nivolumab in Combination With Chemotherapy for FGFR2-positive Metastatic Gastric CancerRecruitingNCT05859477Phase 2
- A Study of Creatine Combined With Curcumin in the Intervention of Early Cachexia in Upper Gastrointestinal TumorsNot yet recruitingNCT05856500Not applicable
- Circulating Biomarker Signatures for the Detection of Gastric Preneoplasia and CancerRecruitingNCT05854368Not applicable
- Surgical Conversion of Candonilimab (AK104) Plus Paclitaxel, S-1 and Apatinib for Unresectable Advanced G/GEJ CancerRecruitingNCT05853172Phase 2
- Acupuncture for Oxaliplatin-induced Peripheral Neuropathy in Gastro-intestinal Cancer PatientsRecruitingNCT05850130Not applicable
- In Vitro Organoid Drug Sensitivity-Guided Treatment for Metastatic Pancreatic and Gastric CancerRecruitingNCT05842187Not applicable
- ONS in Gastric Cancer After Total GastrectomyRecruitingNCT05823272Not applicable
- The Role of Artificial Intelligence in Endoscopic Diagnosis of Esophagogastric Junctional Adenocarcinoma：A Single Center, Case-control, Diagnostic StudyNot yet recruitingNCT05819099
- Exploring the Difference Between Gastric Cardia Cancer and Non-cardia Gastric Cancer Based on MultiomicsRecruitingNCT05812287
- The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection StudyRecruitingNCT05804331
- The Effects of Sufentanil vs. Remifentanil in Total Intravenous Anesthesia With Remimazolam on Postoperative PainRecruitingNCT05785234Not applicable
- A Study to Evaluate Serplulimab in Combination With Docetaxel +S-1 VS. Docetaxel +S-1 as Adjuvant Treatment Therapy in Stage IIIc Gastric CancerRecruitingNCT05769725Phase 2
- BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid LeukemiaRecruitingNCT05768932Phase 1
- Tislelizumab Combined With Chemotherapy in the Cross-line Treatment of First-line Resistant Advanced Gastric CancerNot yet recruitingNCT05751265Phase 2
- CKD-702 Plus Irinotecan in Gastric CancerRecruitingNCT05750290Phase 2
- Omentectomy vs Omental Preservation in Resectable CancerNot yet recruitingNCT05747482Not applicable
- MalnutritiOn Assessment With biOelectrical impedaNce Analysis in gastRic Cancer patIentS Undergoing Multimodal trEatmentRecruitingNCT05723718
- Prediction of Peritoneal Metastasis for Gastric Cancer Based on RadiomicsRecruitingNCT05722275
- Efficacy and Safety of Fruquintinib in Combination With PD-1 Inhibitors as First-line Maintenance Therapy for Advanced HER-2 Negative Gastric Cancer: a Single-arm, Prospective, Exploratory Clinical StudyRecruitingNCT05721651Phase 2
- New Adjuvant Treatment of Locally Advanced Resectable Gastric Cancer With Carelizumab and XELOXRecruitingNCT05715632Not applicable
- Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaRecruitingNCT05702229Phase 2
- Tislelizumab Combined With Apatinib and Oxaliplatin Plus S1 Vs Oxaliplatin Plus S1 as Neoadjuvant Therapy for Borrmann IV、Large Borrmann III Type and Bulky N Positive Advanced Gastric CancerRecruitingNCT05699655Phase 2/3
- Investigating the Experiences of Individuals With Gastric Cancer Participating in Clinical TrialsNot yet recruitingNCT05699278
- Rehabilitation and Recovery for Persons With Esophageal or Gastric CancerRecruitingNCT05698992
- Tranexamic Acid During Upper GI Endoscopic Resection ProceduresRecruitingNCT05688020Phase 4
- Camrelizumab Combined With Irinotecan or Albumin Paclitaxel for Second-line Treatment of Advanced Gastric CancerNot yet recruitingNCT05669807Phase 2
- Treatment of Advance Gastric Cancer With DisulfiramNot yet recruitingNCT05667415Not applicable
- Biomarker Analysis of HIPEC Combined With PD1/PDL1 Inhibitor for Gastric Cancer With Peritoneal MetastasisNot yet recruitingNCT05661110
- Response Prediction of Hyperthermic Intraperitoneal Chemotherapy in Gastro- Intestinal CancerRecruitingNCT05652348
- HIPEC Combined With Sintilimab for Gastric Cancer With Peritoneal MetastasisNot yet recruitingNCT05648487Phase 2
- Fruquintinib Plus Irinotecan in the Treatment of Advanced Gastric CancerNot yet recruitingNCT05643677Phase 2
- REVOLUTION Surgery (REVOLUTION Surgery)RecruitingNCT05642819
- Trastuzumab, Bevacizumab with Paclitaxel for HER2-positive Gastric Cancer in a Second-line TherapyRecruitingNCT05640830Phase 1/2
- Capeox Regimen Combined With Sintilimab and Bevacizumab for Gastric CancerRecruitingNCT05640609Phase 1/2
- Treatment of Advanced Malignant Solid Tumors With Claudin18.2CAR-TRecruitingNCT05620732Not applicable
- Ph2 Study of Savolitinib and Durvalumab (MEDI4736) Combination in Advanced MET Amplified Gastric Cancer(VIKTORY-2)RecruitingNCT05620628Phase 2
- [68Ga]Ga-ABY-025 PET for Quantification of HER2-status in Solid TumorsRecruitingNCT05619016Phase 2
- Clinical Outcomes of Indocyanine Green Tracer Using in Laparoscopic Gastrectomy With Lymph Node Dissection for Remnant Gastric CancerRecruitingNCT05618821Phase 2
- Evaluation of Consistency of PDX Model for Predicting Therapeutic Effect of Gastric CancerRecruitingNCT05616533
- Clinical Efficacy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer With Different ImmunotypesNot yet recruitingNCT05610332Phase 3
- Anxiety Before Non-cardiac Surgery in AdultsRecruitingNCT05596188
- A Biomarker Study for Predicting the Efficacy of Neoadjuvant Sintilimab Plus SOX for Gastric Adenocarcinoma.Not yet recruitingNCT05594381Phase 2
- Transarterial Neoadjuvant Chemotherapy vs.Traditional Intravenous Chemotherapy For Locally Advanced Gastric Cancer With SOX+PD-1RecruitingNCT05593458Phase 3
- Selecting Patients Who May Benefit From Immunotherapy by Tissue-based Biomarkers.RecruitingNCT05593419
- A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid TumorsRecruitingNCT05592626Phase 1/2
- Pilot Study of Stomach Cancer Early Detection and Prevention With EndoscopyRecruitingNCT05566899Not applicable
- Minnelide™ Capsules Alone and in Combination With Paclitaxel in Advanced Gastric CancerRecruitingNCT05566834Phase 1
- Effect and Mechanism of Remimazolam Benzenesulfonate on Enhanced Recovery After Surgery in Patients Undergoing Radical Gastrectomy for Gastric CancerRecruitingNCT05559151Not applicable
- The EpiGASTRIC/EDGAR Project: New Strategies for the Early Detection and Prevention of Gastric CancerRecruitingNCT05551416
- Laparoscopic vs Open Total Gastrectomy for Gastric CancerRecruitingNCT05537129Not applicable
- The Effectiveness and Safety of XELOX and Tislelizumab + PLD for Resectable Gastric Cancer (LidingStudy)RecruitingNCT05536102Phase 2
- Clinical Study of Camrelizumab, Apatinib Mesylate and Nab-paclitaxel Combined With Oxplatin and S-1 in the Neoadjuvant Treatment of Locally Advanced Gastric Cancer With Different GenotypesNot yet recruitingNCT05524974Phase 2
- Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid TumorRecruitingNCT05523947Phase 1/2
- Proximal Gastrectomy Anterior Anastomosis With Pyloroplasty Versus Esophagogastric Anastomosis for Gastric CancerRecruitingNCT05514769Not applicable
- To Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Disitamab Vedotin Combined With RC98 in the Treatment of Subjects With HER2-expressing Locally Advanced or Metastatic Gastric Cancer (Including AEG)RecruitingNCT05514158Phase 1
- Multi-parametric MRI and Dual-energy CT in Patients of Gastric CancerRecruitingNCT05508126
- Effect and Safety of Huaier Granule Versus SOX Regimen in Gastric Cancer PatientsNot yet recruitingNCT05498766Phase 4
- Dual-Port Laparoscopic Distal Gastrectomy for Gastric CancerRecruitingNCT05494086Not applicable
- XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction AdenocarcinomaRecruitingNCT05494060Phase 2
- Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)RecruitingNCT05489211Phase 2
- KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung CancerRecruitingNCT05483491Phase 1
- Different Endoscopic Gastric Cancer Risk AssessmentsRecruitingNCT05458388Not applicable
- OGT-assisted Overlap Esophagojejunostomy Versus Traditional Overlap MethodRecruitingNCT05450835Not applicable
- TCRx_T Cells for Advanced or Recurrent Gastric/Gastroesophageal Junction Cancer After Failure of First ChemotherapyNot yet recruitingNCT05447234Early Phase 1